DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE
The present disclosure relates to dry powder formulations comprising respirable dry particles that comprise 1) dihydroergotamine (DHE) or a salt, hydrate, or polymorph thereof, 2) a monovalent metal cation salt, and 3) one or more excipients; and also relates to methods of using the dry powder for t...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HANSON Dayna F GONZALEZ NELSON Aaron C BERGSON Hillary T CURRAN Aidan K STOLZ Eric C PERRY Jason M |
| description | The present disclosure relates to dry powder formulations comprising respirable dry particles that comprise 1) dihydroergotamine (DHE) or a salt, hydrate, or polymorph thereof, 2) a monovalent metal cation salt, and 3) one or more excipients; and also relates to methods of using the dry powder for the treatment of a migraine, headache, or a symptom thereof, methods of making the dry powder, and receptacles and devices containing the dry powder.
La presente divulgación se refiere a formulaciones de polvo seco que comprenden partículas secas respirables que comprenden 1) dihidroergotamina (DHE) o una sal, hidrato o polimorfo de esta, 2) una sal de catión metálico monovalente y 3) uno o más excipientes; y también se refiere a métodos para usar el polvo seco para el tratamiento de una migraña, cefalea o un síntoma de esta, métodos para preparar el polvo seco y receptáculos y dispositivos que contienen el polvo seco. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2023010120A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2023010120A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2023010120A3</originalsourceid><addsrcrecordid>eNrjZLB28fSIdAnydw1y9w9x9PX0c1VwCYpUCPAPdw1ScPMP8g31cQzx9PcLVnD0c1HwdQ3x8HcJVvB3UwgNduVhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfG-EUYGRsYGhgaGRgaOxkQpAgBUESno</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE</title><source>esp@cenet</source><creator>HANSON Dayna F ; GONZALEZ NELSON Aaron C ; BERGSON Hillary T ; CURRAN Aidan K ; STOLZ Eric C ; PERRY Jason M</creator><creatorcontrib>HANSON Dayna F ; GONZALEZ NELSON Aaron C ; BERGSON Hillary T ; CURRAN Aidan K ; STOLZ Eric C ; PERRY Jason M</creatorcontrib><description>The present disclosure relates to dry powder formulations comprising respirable dry particles that comprise 1) dihydroergotamine (DHE) or a salt, hydrate, or polymorph thereof, 2) a monovalent metal cation salt, and 3) one or more excipients; and also relates to methods of using the dry powder for the treatment of a migraine, headache, or a symptom thereof, methods of making the dry powder, and receptacles and devices containing the dry powder.
La presente divulgación se refiere a formulaciones de polvo seco que comprenden partículas secas respirables que comprenden 1) dihidroergotamina (DHE) o una sal, hidrato o polimorfo de esta, 2) una sal de catión metálico monovalente y 3) uno o más excipientes; y también se refiere a métodos para usar el polvo seco para el tratamiento de una migraña, cefalea o un síntoma de esta, métodos para preparar el polvo seco y receptáculos y dispositivos que contienen el polvo seco.</description><language>eng ; spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231030&DB=EPODOC&CC=MX&NR=2023010120A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231030&DB=EPODOC&CC=MX&NR=2023010120A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HANSON Dayna F</creatorcontrib><creatorcontrib>GONZALEZ NELSON Aaron C</creatorcontrib><creatorcontrib>BERGSON Hillary T</creatorcontrib><creatorcontrib>CURRAN Aidan K</creatorcontrib><creatorcontrib>STOLZ Eric C</creatorcontrib><creatorcontrib>PERRY Jason M</creatorcontrib><title>DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE</title><description>The present disclosure relates to dry powder formulations comprising respirable dry particles that comprise 1) dihydroergotamine (DHE) or a salt, hydrate, or polymorph thereof, 2) a monovalent metal cation salt, and 3) one or more excipients; and also relates to methods of using the dry powder for the treatment of a migraine, headache, or a symptom thereof, methods of making the dry powder, and receptacles and devices containing the dry powder.
La presente divulgación se refiere a formulaciones de polvo seco que comprenden partículas secas respirables que comprenden 1) dihidroergotamina (DHE) o una sal, hidrato o polimorfo de esta, 2) una sal de catión metálico monovalente y 3) uno o más excipientes; y también se refiere a métodos para usar el polvo seco para el tratamiento de una migraña, cefalea o un síntoma de esta, métodos para preparar el polvo seco y receptáculos y dispositivos que contienen el polvo seco.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB28fSIdAnydw1y9w9x9PX0c1VwCYpUCPAPdw1ScPMP8g31cQzx9PcLVnD0c1HwdQ3x8HcJVvB3UwgNduVhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfG-EUYGRsYGhgaGRgaOxkQpAgBUESno</recordid><startdate>20231030</startdate><enddate>20231030</enddate><creator>HANSON Dayna F</creator><creator>GONZALEZ NELSON Aaron C</creator><creator>BERGSON Hillary T</creator><creator>CURRAN Aidan K</creator><creator>STOLZ Eric C</creator><creator>PERRY Jason M</creator><scope>EVB</scope></search><sort><creationdate>20231030</creationdate><title>DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE</title><author>HANSON Dayna F ; GONZALEZ NELSON Aaron C ; BERGSON Hillary T ; CURRAN Aidan K ; STOLZ Eric C ; PERRY Jason M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2023010120A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HANSON Dayna F</creatorcontrib><creatorcontrib>GONZALEZ NELSON Aaron C</creatorcontrib><creatorcontrib>BERGSON Hillary T</creatorcontrib><creatorcontrib>CURRAN Aidan K</creatorcontrib><creatorcontrib>STOLZ Eric C</creatorcontrib><creatorcontrib>PERRY Jason M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HANSON Dayna F</au><au>GONZALEZ NELSON Aaron C</au><au>BERGSON Hillary T</au><au>CURRAN Aidan K</au><au>STOLZ Eric C</au><au>PERRY Jason M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE</title><date>2023-10-30</date><risdate>2023</risdate><abstract>The present disclosure relates to dry powder formulations comprising respirable dry particles that comprise 1) dihydroergotamine (DHE) or a salt, hydrate, or polymorph thereof, 2) a monovalent metal cation salt, and 3) one or more excipients; and also relates to methods of using the dry powder for the treatment of a migraine, headache, or a symptom thereof, methods of making the dry powder, and receptacles and devices containing the dry powder.
La presente divulgación se refiere a formulaciones de polvo seco que comprenden partículas secas respirables que comprenden 1) dihidroergotamina (DHE) o una sal, hidrato o polimorfo de esta, 2) una sal de catión metálico monovalente y 3) uno o más excipientes; y también se refiere a métodos para usar el polvo seco para el tratamiento de una migraña, cefalea o un síntoma de esta, métodos para preparar el polvo seco y receptáculos y dispositivos que contienen el polvo seco.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_MX2023010120A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T03%3A14%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HANSON%20Dayna%20F&rft.date=2023-10-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2023010120A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |